Capital International Inc’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,465
Closed -$1.34M 336
2023
Q2
$1.34M Buy
10,465
+227
+2% +$27.5K 0.02% 272
2023
Q1
$1.19M Buy
10,238
+205
+2% +$22.9K 0.02% 247
2022
Q4
$1.14M Sell
10,033
-655
-6% -$71.9K 0.02% 252
2022
Q3
$861K Sell
10,688
-5,579
-34% -$473K 0.02% 264
2022
Q2
$1.21M Buy
16,267
+1,859
+13% +$170K 0.02% 244
2022
Q1
$1.84M Buy
14,408
+8,224
+133% +$900K 0.02% 244
2021
Q4
$830K Buy
+6,184
New +$889K 0.01% 281

Other funds holding DXCM

Capital International Inc's DXCM Position: Q3 2023 in Review

Capital International Inc sold out of DexCom (DXCM) in Q3 2023, closing a stake of 10,465 shares — an estimated $1.34M sold.

Capital International Inc first reported a position in DXCM in Q4 2021 and held it in 7 quarters. The position peaked at $1.84M in Q1 2022. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Capital International Inc reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Capital International Inc sold 10,465 DexCom shares in Q3 2023, an estimated $1.34M.
  • Capital International Inc first reported a position in DexCom in Q4 2021 and held it in 7 quarters.
  • Capital International Inc's DexCom position peaked at $1.84M in Q1 2022.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Capital International Inc's 13F filing for Q3 2023, filed 13 Nov 2023.